$10.37
0.68% today
Nasdaq, Sep 16, 08:14 pm CET
ISIN
US74019P1084
Symbol
DTIL
Sector
Industry

Precision BioSciences, Inc. Stock price

$10.30
+1.35 15.08% 1M
-1.27 10.98% 6M
-0.65 5.94% YTD
-2.59 20.12% 1Y
-370.70 97.30% 3Y
-283.70 96.50% 5Y
-469.70 97.85% 10Y
Nasdaq, Closing price Fri, Sep 13 2024
-0.19 1.81%
ISIN
US74019P1084
Symbol
DTIL
Sector
Industry

Key metrics

Market capitalization $41.86m
Enterprise Value $-50.90m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.77
EV/Sales (TTM) EV/Sales -0.58
P/S ratio (TTM) P/S ratio 0.48
P/B ratio (TTM) P/B ratio 0.98
Revenue growth (TTM) Revenue growth 88.35%
Revenue (TTM) Revenue $87.64m
EBIT (operating result TTM) EBIT $-7.29m
Free Cash Flow (TTM) Free Cash Flow $-65.84m
Cash position $123.57m
EPS (TTM) EPS $-2.00
P/E forward 6.04
P/S forward 0.64
EV/Sales forward negative
Short interest 3.30%
Show more

Is Precision BioSciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Precision BioSciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Precision BioSciences, Inc. forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Precision BioSciences, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Precision BioSciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
50 50
152% 152%
100%
- Direct Costs 1.38 1.38
42% 42%
3%
49 49
179% 179%
97%
- Selling and Administrative Expenses 6.61 6.61
1% 1%
13%
- Research and Development Expense 16 16
19% 19%
33%
26 26
366% 366%
51%
- Depreciation and Amortization 1.38 1.38
42% 42%
3%
EBIT (Operating Income) EBIT 24 24
301% 301%
48%
Net Profit 33 33
375% 375%
66%

In millions USD.

Don't miss a Thing! We will send you all news about Precision BioSciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Precision BioSciences, Inc. Stock News

Neutral
Business Wire
12 days ago
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, gene insertion, and gene excision, today announced that the Company will participate in a panel discussion and fireside chat at the H.C. Wain...
Neutral
Business Wire
about one month ago
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, gene insertion, and gene excision, today announced that its partner TG Therapeutics has received U.S. Food and Drug Administration (FDA) clea...
Neutral
InvestorPlace
about one month ago
With the market struggling amid rising recession fears, now may be the ideal time to consider biotech stocks. First, the sector itself is a financially lucrative one.
More Precision BioSciences, Inc. News

Company Profile

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's propriety genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane in January 2006 and is headquartered in Durham, NC.

Head office United States
CEO Michael Amoroso
Employees 109
Founded 2006
Website www.precisionbiosciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today